Velmupressin(Synonyms: c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2)

Velmupressin;(Synonyms: c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2)

Velmupressin (c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2) 是一种有效选择性的、短效肽的 V2 受体 (V2R) 激动剂,对 hV2R 和 rV2R 的 EC50 值分别为 0.07 和 0.02 nM。

Velmupressinamp;;(Synonyms: c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2)

Velmupressin Chemical Structure

CAS No. : 1647119-61-6

规格 是否有货
100 mg ; 询价 ;
250 mg ; 询价 ;
500 mg ; 询价 ;

* Please select Quantity before adding items.

生物活性

Velmupressin (c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2) is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07 and 0.02 nM for hV2R and rV2R, respectively[1].

IC50 Target

EC50: 0.07 nM (hV2R), 0.02 nM (rV2R)[1]

分子量

946.58

Formula

C42H60ClN11O8S2

CAS 号

1647119-61-6

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Wiśniewski K, et al. Discovery of Potent, Selective, and Short-Acting Peptidic V2 Receptor Agonists. J Med Chem. 2019 May 23;62(10):4991-5005.

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm;

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm 是一种有效选择性的、短效肽的 V2 受体 (V2R) 激动剂,对 hV2R 和rV2R EC50 值分别为 0.25 和 0.05 nM。

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agmamp;;

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm Chemical Structure

CAS No. : 1647119-71-8

规格 是否有货
100 mg ; 询价 ;
250 mg ; 询价 ;
500 mg ; 询价 ;

* Please select Quantity before adding items.

生物活性

c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm is a is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.25 and 0.05 nM for hV2R and rV2R, respectively[1].

IC50 Target

EC50: 0.25 nM (hV2R), 0.05 nM (rV2R)[1]

分子量

1045.71

Formula

C47H69ClN12O9S2

CAS 号

1647119-71-8

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Wiśniewski K, et al. Discovery of Potent, Selective, and Short-Acting Peptidic V2 Receptor Agonists. J Med Chem. 2019 May 23;62(10):4991-5005.